Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacy performance while providing continuous medication monitoring.
Doucette WR, McDonough RP, Herald F, Goedken A, Funk J, Deninger MJ. Doucette WR, et al. Among authors: goedken a. J Am Pharm Assoc (2003). 2017 Nov-Dec;57(6):692-697. doi: 10.1016/j.japh.2017.07.006. Epub 2017 Aug 24. J Am Pharm Assoc (2003). 2017. PMID: 28844583
Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit.
Goedken AM, Urmie JM, Farris KB, Doucette WR. Goedken AM, et al. J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):18-25. doi: 10.1331/JAPhA.2009.08001. J Am Pharm Assoc (2003). 2009. PMID: 19196592
MAIN OUTCOME MEASURES: Number of prescriptions used by a beneficiary in the month before the survey and the intention of the beneficiary to enroll in the Medicare drug benefit. ...Individuals reporting worse health status and a higher number of prescriptions indicat …
MAIN OUTCOME MEASURES: Number of prescriptions used by a beneficiary in the month before the survey and the intention of the benefici …
Development of a medication monitoring attitude measure using a mixed methods item development process.
Witry MJ, Wesely PM, Goedken AM, Ernst EJ, Sorofman BA, Doucette WR. Witry MJ, et al. Among authors: goedken am. Int J Pharm Pract. 2016 Feb;24(1):49-59. doi: 10.1111/ijpp.12185. Epub 2015 Mar 10. Int J Pharm Pract. 2016. PMID: 25756349
Continuous Medication Monitoring (CoMM): A foundational model to support the clinical work of community pharmacists.
Goedken AM, Butler CM, McDonough RP, Deninger MJ, Doucette WR. Goedken AM, et al. Res Social Adm Pharm. 2018 Jan;14(1):106-111. doi: 10.1016/j.sapharm.2016.12.008. Epub 2017 Jan 2. Res Social Adm Pharm. 2018. PMID: 28087207
Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
Urmie JM, Farris KB, Doucette WR, Goedken AM. Urmie JM, et al. J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):72-81. doi: 10.1331/JAPhA.2011.09239. J Am Pharm Assoc (2003). 2011. PMID: 21247829
One-third of all participants and almost one-half of Medicare Part D participants had requested a less expensive prescription. Among those participants, 70% received a less expensive prescription and most thought it worked about the same as the more expensive prescr …
One-third of all participants and almost one-half of Medicare Part D participants had requested a less expensive prescription. Among …
Medication-Related Problems Identified Through Continuous Medication Monitoring.
Goedken AM, Huang S, McDonough RP, Deninger MJ, Doucette WR. Goedken AM, et al. Pharmacy (Basel). 2018 Aug 20;6(3):86. doi: 10.3390/pharmacy6030086. Pharmacy (Basel). 2018. PMID: 30127287 Free PMC article.
Provider Visits for Asthma: Potential Barriers for Insured Children.
Goedken AM, Urmie JM, Polgreen LA. Goedken AM, et al. Glob J Health Sci. 2015 Feb 24;7(5):96-105. doi: 10.5539/gjhs.v7n5p96. Glob J Health Sci. 2015. PMID: 26156910 Free PMC article.
Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.
Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Kulchaitanaroaj P, et al. Among authors: goedken am. J Hypertens. 2017 Jan;35(1):178-187. doi: 10.1097/HJH.0000000000001126. J Hypertens. 2017. PMID: 27684354
Application of a framework for determining number of drugs.
Goedken AM, Lund BC, Cook EA, Schroeder MC, Brooks JM. Goedken AM, et al. BMC Res Notes. 2016 May 13;9:272. doi: 10.1186/s13104-016-2076-5. BMC Res Notes. 2016. PMID: 27178197 Free PMC article.
Once-daily abacavir in place of twice-daily administration.
Goedken AM, Herman RA. Goedken AM, et al. Ann Pharmacother. 2005 Jul-Aug;39(7-8):1302-8. doi: 10.1345/aph.1E680. Epub 2005 Jun 14. Ann Pharmacother. 2005. PMID: 15956231 Review.
OBJECTIVE: To review the safety and efficacy of a once-daily dosage regimen for abacavir, a nucleoside reverse transcriptase inhibitor. ...
OBJECTIVE: To review the safety and efficacy of a once-daily dosage regimen for abacavir, a nucleoside reverse transcriptase i …
14 results
Jump to page
Feedback